Trial Details
RECRUITINGBasic Information
| Clinical ID | c1049 |
|---|---|
| Identifier | NCT05643534 |
| Trial Title | Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation (IBS-C) |
| Interventions | DRUG: Tenapanor 50 MG|DRUG: Tenapanor 25 mg bid|DRUG: Placebo |
Participant Information
| Sponsor | Ardelyx |
|---|---|
| City | Foley |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2022-11-15 |
|---|---|
| Primary Completion Date | 2026-06-01 |
| Completion Date | 2026-06-01 |